All stock lists
Inogen Inc (NASDAQ:INGN)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
7.03-0.07 (-0.99%)
Insider Score
––Not scored
INGN Insider Score
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
INGN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 95.08 M | 85.11 M | 81.72 M | 92.39 M | 92.28 M | 82.28 M |
| Revenue Growth (YoY) | 3.04 % | 3.44 % | 2.05 % | 4.00 % | 3.96 % | 5.45 % |
| Cost of Revenue | 51.81 M | 43.34 M | 40.50 M | 45.44 M | 50.94 M | 45.91 M |
| Gross Profit | 43.27 M | 41.77 M | 41.22 M | 46.95 M | 41.34 M | 36.37 M |
| SG&A Expense | 42.50 M | 42.10 M | 39.23 M | 43.59 M | 42.26 M | 39.99 M |
| R&D Expense | 5.87 M | 5.10 M | 5.32 M | 4.84 M | 5.21 M | 4.03 M |
| Operating Expenses | 48.37 M | 50.19 M | 50.53 M | 54.07 M | 47.47 M | 44.03 M |
| Operating Income | -5.10 M | -8.42 M | -9.31 M | -7.12 M | -6.13 M | -7.66 M |
| Pretax Income | -4.00 M | -8.50 M | -7.36 M | -5.44 M | -4.30 M | -6.27 M |
| Tax Provision | -154.00 K | -174.00 K | -236.00 K | -146.00 K | -153.00 K | -97.00 K |
| Net Income | -3.85 M | -8.32 M | -7.13 M | -5.29 M | -4.15 M | -6.17 M |
| EPS (Basic) | -0.14 | -0.30 | -0.26 | -0.20 | -0.15 | -0.25 |
| EPS (Diluted) | -0.14 | -0.30 | -0.26 | -0.20 | -0.15 | -0.25 |
| Shares Outstanding | 27.05 M | 27.32 M | 27.18 M | 26.41 M | 26.96 M | 25.16 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.